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min. The investigated influence were demographic charac-
teristics, surgical risk score related to physical status (based 
on the American Society of Anesthesiologists [ASA] classifi-
cation), comorbidities, type and duration of surgery, and
duration of anesthesia on IOH occurrence. The investigated 
factors were obtained from the patients’ medical history,
anesthesia charts, and the daily practice database. Logistic 
regression analysis was done to determine the predictors of 
IOH.  Results: Of the 269 patients, 153 (56.9%) had IOH. Based 
on the univariate analysis, age, body mass index, ASA status, 
duration of anesthesia, and preoperative hypertension were 
risk factors for the occurrence of IOH. Multivariate analysis 
showed that independent predictors of IOH were a history 
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 Abstract 
 Objective: To investigate the incidence and identify risk fac-
tors for the occurrence of intraoperative hypertension (IOH) 
during surgery for primary hyperparathyroidism (pHPT). 
 Subjects and Methods: The study included 269 patients sur-
gically treated between January 2008 and January 2012 for 
pHPT. IOH was defined as an increase in systolic blood pres-
sure  ≥ 20% compared to baseline values which lasted for 15 
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 Significance of the Study 
 • In this study the independent predictors for the occurrence of intraoperative hypertension during sur-
gery of primary hyperparathyroidism were a history of hypertension and age. Hence, the patients at 
risk could be identified and the occurrence of intraoperative hypertension and its potential complica-
tions could be prevented, thereby leading to safer parathyroid surgery. 
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of hypertension (OR = 2.080, 95% CI: 1.102–3.925,  p = 0.024) 
and age (OR = 0.569, 95% CI: 0.360–0.901,  p = 0.016).  Conclu-
sion: In this study, a high percentage (56%) of the patients 
developed IOH during surgery for pHPT, which indicates that 
special attention should be paid to these patients, especially 
to the high-risk groups: older patients and those with a his-
tory of hypertension. Further, this study showed that ad-
vanced age and hypertension as a coexisting disease prior to 
parathyroid surgery were independent risk factors for the 
occurrence of IOH.  © 2017 S. Karger AG, Basel 
 Introduction 
 Primary hyperparathyroidism (pHPT) is character-
ized by hypercalcemia, which occurs due to excessive se-
cretion of parathyroid hormone (PTH). The pathoana-
tomic substrate of the disease is most commonly parathy-
roid adenoma (80–85%; double adenoma is found in 
about 5%), hyperplasia of the parathyroid glands (10–
15%), and carcinoma (1%)  [1] .
 pHPT occurs in approximately 1% of the population 
over 40 years of age  [2] . Patients suffering from symp-
tomatic forms of pHPT can develop various complica-
tions that might lead to poor treatment outcome, mainly 
due to the increased incidence of cardiovascular diseases 
 [3] . pHPT may lead to structural and functional altera-
tions in the cardiovascular system. Hypertension is one of 
the most common manifestations of such disturbances in 
pHPT  [4] . The presence of hypertension has been report-
ed in 20–60% of patients with pHPT  [5–7] . In addition to 
hypertension, increased occurrence of cardiac arrhyth-
mias was demonstrated in patients with pHPT  [8] , a high 
prevalence of left ventricular hypertrophy  [9] ,  increased 
 stiffness of both central and peripheral arteries  [10] ,  and 
impairment of catecholamine response to physical stress, 
i.e., adrenergic dysfunction  [11] .
 Currently, one study  [12] has analyzed perioperative 
management difficulties, with the development of intra-
operative hypertension (IOH) during parathyroidectomy. 
However, the study included 292 patients treated for pri-
mary, secondary, and tertiary hyperparathyroidism, of 
which only 96 patients belonged to the group with pHPT. 
Because the primary procedure for treatment of pHPT is 
surgical excision of the enlarged parathyroid glands  [13] 
and since IOH might lead to various cardiovascular com-
plications (intra- and postoperatively), the aim of this 
study was to investigate the incidence and identify the risk 
factors for the occurrence of IOH during pHPT surgery.
 Subjects and Methods 
 This was a retrospective study conducted between January 
2008 and January 2012 at the Center for Endocrine Surgery, Clin-
ical Center of Serbia, Belgrade. The study was approved by the 
Ethics Committee of the Clinical Center of Serbia, Belgrade.
 A total of 269 patients >18 years surgically treated for pHPT 
were included in the study. The exclusion criteria were a diag-
nosis of pheochromocytoma, hypothyroidism, hyperthyroid-
ism, and Conn and Cushing syndromes. The patients were di-
vided into 2 groups: those with ( n = 153) and without IOH ( n = 
116). IOH was defined as an increase of systolic blood pressure 
(SBP)  ≥ 20% compared to the baseline values, during 15 min. 
The basal value of SBP was defined as the average value of all 
measured SBPs recorded during the preoperative evaluation of 
patients.
 All operations were performed under general endotracheal 
anesthesia. Patients were premedicated 20 min prior to surgery 
(using 0.1 mg/kg midazolam and 0.5 mg atropine given intra-
muscularly). During anesthesia induction, all patients received 
0.05–0.1 mg fentanyl and 1.5 mg/kg propofol. In order to facili-
tate tracheal intubation, 1.1 mg/kg succinylcholine was used and 
further relaxation was achieved with 0.5 mg/kg rocuronium. An-
esthesia was maintained with fentanyl (5 μg/kg) and a mixture of 
gases: air (2 L/min), oxygen (2 L/min), and sevoflurane in appro-
priate concentrations.
 Noninvasive blood pressure, heart rate, and oxygen satura-
tion were recorded in anesthesia charts every 5 min, and cardiac 
rhythm was monitored using continuous ECG monitoring. IOH 
was marked from the moment of anesthesia induction until ex-
tubation of the patient.
 General characteristics of the patients, coexisting diseases, an-
esthesia, and surgery characteristics were obtained using the pa-
tients’ medical records, anesthesia charts, and daily practice da-
tabase. The following factors were investigated: the influence of 
age, gender, body mass index (BMI), ASA status (the surgical risk 
score related to physical status based on the American Society of 
Anesthesiologists classification), type of surgery (extirpation of 
the adenoma/subtotal parathyroidectomy), duration of the pro-
cedure (min), time under general endotracheal anesthesia (min), 
and coexisting diseases (hypertension, cardiac rhythm distur-
bances, cardiomyopathy, ischemic heart disease, diabetes melli-
tus, dyslipidemia, and renal dysfunction) on the occurrence of 
IOH.
 Statistical Analysis 
 Statistical analyses were performed using SPSS 22.0 (Chicago, 
IL, USA). Numerical variables are expressed as mean values ± SD, 
while the other categorical variables are shown as absolute num-
bers and percentages. The normality of data distribution was 
checked by a one-sample Kolmogorov-Smirnov test. A Student  t 
test was used to compare mean values of the parametric features 
and a Mann-Whitney test was used to compare the nonparamet-
ric parameters. A Pearson χ 2 test and McNemar test were used to 
compare the differences in frequency of categorical features. All 
variables that were statistically significant in univariate analysis, 
at the level of significance of  p < 0.05, were included in the mul-
tivariate logistic regression analysis.
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 Results 
 Of the 269 patients, 153 (56.9%) had IOH. The young-
est patient was 19 years old and the oldest was 83 years 
old. The median age was 59 years and there were 233 fe-
males (86.6%) and 36 males (13.4%). The mean duration 
of surgery was 41.03 ± 17.06 min, and the mean time un-
der general endotracheal anesthesia was 50.56 ± 18.21 
min. Of the 269 patients, 171 (63.6%) were classified as 
ASA II status and 151 (56.3%) had a BMI  ≥ 25; regarding 
the degree of IOH, 203 (75.5%) had SBP values  ≥ 140 mm 
Hg. The basic characteristics of the patients are presented 
in  Table 1 .
 The comparative characteristics of patients with and 
without IOH are shown in  Table 2 . There was no signifi-
cant difference regarding gender. In general, patients 
with IOH were statistically significantly older. Also, a sig-
nificant number of patients older than 61 years had IOH 
( n = 82; 53.6%). Significantly more patients with ASA III 
status were in the group with IOH compared to the group 
without IOH ( n = 50 [32.37%] vs.  n = 27 [23.3%],  p = 
0.009). In the group with IOH, there were statistically sig-
nificantly more patients with BMI >25 ( n = 96 [63.2%] vs. 
 n = 55 [47.4%],  p = 0.006). Significantly more patients 
with IOH had preoperative hypertension compared to 
patients without IOH ( n = 122 [79.7%] vs.  n = 62 [53.4%], 
 p = 0.000). In the group with IOH, the duration of anes-
thesia and the duration of the surgical procedure were 
significantly longer ( p = 0.042 and 0.029, respectively). 
The type of operation did not differ between the observed 
groups.
 No significant differences between the groups were re-
corded regarding the incidence of preoperative comor-
bidities: cardiac rhythm disorders, cardiomyopathy, isch-
emic heart disease, diabetes mellitus, hyperlipoprotein-
emia, and renal insufficiency ( Table 3 ).
 Based on the univariate analysis, the risk factors for the 
occurrence of IOH were age (OR = 0.467, 95% CI: 0.318–
0.685,  p = 0.000), BMI (OR = 0.633, 95% CI: 0.422–0.950, 
 p = 0.027), ASA status (OR = 0.555, 95% CI: 0.357–0.864, 
 p = 0.009), duration of anesthesia (OR = 0.986, 95% CI: 
0.972–1.000,  p = 0.049), and preoperative hypertension 
 Table 1.  Basic characteristics of patients
IOH
With 153 (56.9)
Without 116 (43.1)
Gender
Male 36 (13.4)
Female 233 (86.6)
Age, years 56.79 ± 12.65
BMI
≤20 15 (5.6)
20.01–25 102 (38.1)
>25.01 151 (56.3)
ASA status
I 21 (7.8)
II 171 (63.6)
III 77 (28.6)
Duration of surgery, min 41.03 + 17.06
Duration of anesthesia, min 50.56 + 18.21
Degree of IOH
≥140 mm Hg 203 (75.5)
<140 mm Hg 66 (24.5)
 Values are presented as n (%) or means ± SD. BMI, body mass 
index; ASA, physical status based on American Society of Anesthe-
siologists classification; IOH, intraoperative hypertension.
 Table 2.  Comparative characteristics of patients with and without 
intraoperative hypertension
IOH p 
valuewit h without
Gender 0.863
Male 20 (13.1) 16 (13.8)
Female 133 (86.9) 100 (86.2)
Age 0.000
≤40 years 11 (7.2) 19 (16.4)
41 – 60 years 60 (39.2) 62 (53.4)
≥61 years 82 (53.6) 35 (30.2)
BMI 0.006
≤20 8 (5.3) 7 (6.0)
20.01 – 25 48 (31.06) 54 (46.6)
≥25.01 96 (63.2) 55 (47.4)
ASA status 0.009
I 6 (3.9) 15 (12.9)
II 97 (63.4) 74 (63.8)
III 50 (32.37) 27 (23.3)
Type of operation 0.223
Extirpation 144 (94.7) 107 (93)
Subtotal 7 (4.6) 4 (3.5)
Other 1 (0.7) 4 (3.5)
Preoperative hypertension 0.000
Yes 122 (79.7) 62 (53.4)
No 31 (20.3) 54 (46.6)
Duration of surgery, min 42.61 + 17.38 38.91 + 16.46 0.042
Duration of anesthesia,
min 52.48 + 18.66 48.00 + 17.34 0.029
 Values are presented as n (%) or means ± SD. BMI, body mass 
index; ASA status, physical status based on American Society of 
Anesthesiologists classification; IOH, intraoperative hyperten-
sion.
 Sabljak   et al.
 
Med Princ Pract 2017;26:381–386
DOI: 10.1159/000475597
384
(OR = 3.428, 95% CI: 2.003–5.865,  p = 0.000). Multivari-
ate analysis showed that independent predictors of IOH 
were a history of hypertension (OR = 2.080, 95% CI: 
1.102–3.925,  p = 0.024) and age (OR = 0.569, 95% CI: 
0.360–0.901,  p = 0.016) ( Table 4 ).
 Discussion 
 In this study, the 56.9% incidence rate of IOH was sim-
ilar to the 54.1% reported by Corneci et al.  [12] and com-
parable to the 61.4% in thyroidectomy  [14] .
 The high incidence rate could be due to several factors. 
Hulter et al.  [15] suggested a theory that hypertension as-
sociated with pHPT results from either direct or indirect 
effects of PTH excess. Later studies confirmed this theory 
 [16, 17] because PTH directly stimulates activity of the 
renin-aldosterone system and thus leads to an increase in 
blood pressure  [18, 19] . Of equal importance, it has been 
reported that PTH has a secretagogue effect on stress hor-
mones of the adrenal cortex – aldosterone and cortisol – 
which, at least in part, may explain hypertension in pHPT 
 [20] .  Hypertension could be caused by increased levels of 
blood calcium, intracellular calcium, and hypomagnesae-
mia. Nilsson et al.  [21] reported that acute hypercalcemia 
caused by calcium infusion in healthy subjects led to 
dose-dependent disorders of vasodilatory endothelial 
function and increased SBP  [21] . Hypertension second-
ary to pHPT is still being debated  [22] . The 54.1% inci-
dence rate of hypertension in pHPT is within the range of 
20–69% reported in various studies  [5, 23, 24] . This large 
variation in reported incidence could be due to variations 
between different authors due to differences in blood 
pressure measurement criteria of hypertension and dif-
ferent patient characteristics. IOH during pHPT surgery 
might be caused by surgical manipulation of the glands, 
which can lead to PTH insertion into the bloodstream, 
which might cause an increase in blood pressure. The 
findings of this study indicate that approximately every 
other pHPT patient might develop IOH during parathy-
roidectomy. Because IOH has been marked as an inde-
pendent risk factor for various perioperative complica-
tions, particularly after long procedures  [25] , it could sub-
stantially compromise the treatment outcome.
 Table 4.  Uni- and multivariate logistic regression
Variable Univariate  Multivariate
OR (95% CI) p value OR ( 95% CI) p value
Age 0.467 (0.318 – 0.685) 0.000 0.569 (0.360 – 0.901) 0.016
BMI 0.633 (0.422 – 0.950) 0.027 0.774 (0.499 – 1.200) 0.252
ASA status 0.555 (0.357 – 0.864) 0.009 0.926 (0.555 – 1.544) 0.768
Duration of anesthesia 0.986 (0.972 – 1.000) 0.049 0.985 (0.970 – 1.000) 0.055
Preoperative hypertension 3.428 (2.003 – 5.865) 0.000 2.080 (1.102 – 3.925) 0.024
 BMI, body mass index; ASA status, physical status based on American Society of Anesthesiologists classifica-
tion.
 Table 3.  Comorbidities of patients with and without intraoperative hypertension (IOH)
Comorbidities  IOH, n (%) p value
w ith without 
Preoperative cardiac rhythm disorders 26 (17.0) 28 (24.1) 0.147
Preoperative cardiomyopathy 9 (5.9) 6 (5.2) 0.802
Preoperative ischemic heart disease 17 (11.1) 10 (8.6) 0.501
Preoperative diabetes mellitus 20 (13.1) 9 (7.80) 0.164
Preoperative hyperlipoproteinemia 17 (11.1) 18 (15.5) 0.278
Preoperative renal insufficiency 9 (5.9) 9 (7.8) 0.542
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 In this study, the finding that over 79% of patients had 
previous hypertension is consistent with those of previ-
ous studies  [26–29] . Hypertension in general is the most 
common comorbidity in surgical patients – preexisting 
hypertension is present in over two-thirds of all patients 
over 60 years of age  [27] , and the vast majority of these 
patients were in advanced age in which the prevalence of 
the disease is more frequent. Prys-Roberts  [28] reported 
that hypertension that exists preoperatively increases the 
probability of its occurrence during the surgery  [28] . In a 
meta-analysis, Howell et al.  [29] reported that patients 
with hypertension prior to surgery had a 1.31-fold higher 
risk for the occurrence of cardiovascular complications, 
compared with normotensive patients. Although hyper-
tension is associated with increased hemodynamic insta-
bility in the perioperative period, a direct and indepen-
dent correlation between preoperative hypertension and 
perioperative complications is unclear  [30] . There are a 
few studies which show preoperative hypertension is an 
independent predictor of IOH occurrence  [12, 28] . This 
study is one of them.
 The limitations of this study include: (1) the study 
was neither controlled nor randomized and could hence 
lead to preselection bias, (2) the duration and degree of 
IOH were not sufficiently investigated and the type of 
antihypertensive drugs the patients used preoperatively 
were not taken into account, and (3) the literature search 
and review included only “English and Serbian lan-
guage” articles, so language bias may exist in our discus-
sion.
 Conclusion 
 This study showed that advanced age and hyperten-
sion as a coexisting disease prior to parathyroid surgery 
represent independent risk factors for the occurrence of 
IOH. In these subgroups, we recommend that special at-
tention be paid to them during anesthetic evaluation in 
order to avoid potential complications, primarily hemo-
dynamic instability.
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